Chris LaVictoire Mahai Insider Trades & Stock Holdings

Director · abrdn World Healthcare Fund · Latest filing Jul 16, 2026

Chris LaVictoire Mahai, Director at abrdn World Healthcare Fund has 4 Form 4 trades on file since Jul 16, 2026 across 4 companies. Open-market activity: 4 purchases ($42.01K) and 0 sales ($0), net +$42.01K. Latest filing: acquired 796 shares of $THW on Jul 16, 2026 at $13.20.

Trades on file
4
Open-market bought
$42.01K
Open-market sold
$0
Net open-market
+$42.01K
Shares held ($THW)
796
Latest filing
Jul 16, 2026

Shares held by Chris LaVictoire Mahai

Shares owned after the most recent Form 4 for each company.

All insider trades by Chris LaVictoire Mahai

DateTicker TypeSharesPriceValue Owned afterΔOwn 1W1M6MRoleFilingStory
$THW Buy (Open-market buy) 796 $13.20 $10.51K 796 Director SEC —
$HQL Buy (Open-market buy) 527 $19.92 $10.50K 527 Director SEC —
$THQ Buy (Open-market buy) 568 $18.49 $10.50K 568 Director SEC —
$HQH Buy (Open-market buy) 501 $20.96 $10.50K 501 Director SEC —

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Chris LaVictoire Mahai traded

Frequently asked questions

Has Chris LaVictoire Mahai been buying or selling stock?

Chris LaVictoire Mahai has 4 open-market purchases and 0 open-market sales on file, net +$42.01K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Chris LaVictoire Mahai's latest insider trade?

acquired 796 shares of $THW on Jul 16, 2026 at $13.20.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text

SMS Terms

By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.

Full terms and conditions